抗-HCV和HCV-RNA检测及其与ALT的相关性分析

目的探讨化学免疫发光法(CLIA)定量检测抗-HCV和FQ-PCR法检测HCV-RNA含量与丙氨酸氨基转移酶(ALT)水平的相关性。方法用CLIA定量筛选抗-HCV阳性的100例病人标本,以荧光定量PCR法检测HCV-RNA含量和酶速率法检测ALT浓度水平,并对所得数据进行统计分析。结果在100份抗-HCV阳性标本中,检出HCV-RNA阳性者76例,阳性率为76%。随着抗-HCV的S/CO值增高,HCV-RNA检出率增高较明显;ALT水平与HCV-RNA含量无显著相关性(P>0.05),但ALT异常率与HCV-RNA含量呈正相关。结论在HCV诊断与疗效观察中,血清抗HCV、HCV-RNA和ALT指标各有利弊,3者有机结合能正确诊断和预测肝脏损伤及评价疗效。

Quantitative analysis of serum anti-HCV,HCV-RNA and ALT

Objective To analyze the correlation among the quantitative detection of serum anti-HCV by chemiluminescene immunoassay(CLIA), the content of HCV-RNA and alanine aminotransferase (ALT) levels. Methods The sera from 100 patients with CLIA positive results were used in this study. The level of serum HCV-RNA and ALT was detected by real-time fluorescent quantitative assay (FQ-PCR) and enzyme-rate method, respectively. The data were analyzed by statistical method. Results 76 patients were found HCV-RNA positive, with a positive rate of 76%. The HCV-RNA positive rate was positively correlated with the anti-HCV S/CO result. There was no correlation between the level of ALT and the content of HCV-RNA(P>0.05),but the content of HCV-RNA was correlated with the ALT. Conclusion The level of anti-HCV antibody,HCV-RNA and ALT should all be used in the diagnosis of HCV. An appropriate combination of these indexes has important clinical significance in the diagnosis, prediction of liver injury and early treatment.